1 – 16 of 16
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The circular RNome of primary breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
2018) In Annals of Oncology(
- Contribution to journal › Article
- 2017
-
Mark
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
(
- Contribution to journal › Article
-
Mark
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
(
- Contribution to journal › Article
- 2016
-
Mark
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
(
- Contribution to journal › Article
-
Mark
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients
(
- Contribution to journal › Article
-
Mark
The topography of mutational processes in breast cancer genomes
(
- Contribution to journal › Article
-
Mark
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
(
- Contribution to journal › Article
-
Mark
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
(
- Contribution to journal › Article
-
Mark
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
(
- Contribution to journal › Article
- 2015
-
Mark
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
(
- Contribution to journal › Article
- 2014
-
Mark
Ferritin heavy chain in triple negative breast cancer : a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response
(
- Contribution to journal › Article
-
Mark
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Signatures of mutational processes in human cancer
(
- Contribution to journal › Article